Found: 2
Select item for more details and to access through your institution.
Treatment with recombinant human erythropoietin is associated with rejuvenation of CD8+ T cell compartment in chronic renal failure patients.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. 11, p. 3221, doi. 10.1093/ndt/gfm361
- By:
- Publication type:
- Article
Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients.
- Published in:
- Nephrology Dialysis Transplantation, 2005, v. 20, n. 2, p. 367, doi. 10.1093/ndt/gfh589
- By:
- Publication type:
- Article